APA

Miller C., Kirchmair R., Troger J., Saria A., Fleischhacker W. W., Fischer-Colbrie R., Benzer A. & Winkler H. (19970529). CSF of neuroleptic-naive first-episode schizophrenic patients: levels of biogenic amines, substance P, and peptides derived from chromogranin A (GE-25) and secretogranin II (secretoneurin). : Biological psychiatry.

Chicago

Miller C, Kirchmair R, Troger J, Saria A, Fleischhacker W W, Fischer-Colbrie R, Benzer A and Winkler H. 19970529. CSF of neuroleptic-naive first-episode schizophrenic patients: levels of biogenic amines, substance P, and peptides derived from chromogranin A (GE-25) and secretogranin II (secretoneurin). : Biological psychiatry.

Harvard

Miller C., Kirchmair R., Troger J., Saria A., Fleischhacker W. W., Fischer-Colbrie R., Benzer A. and Winkler H. (19970529). CSF of neuroleptic-naive first-episode schizophrenic patients: levels of biogenic amines, substance P, and peptides derived from chromogranin A (GE-25) and secretogranin II (secretoneurin). : Biological psychiatry.

MLA

Miller C, Kirchmair R, Troger J, Saria A, Fleischhacker W W, Fischer-Colbrie R, Benzer A and Winkler H. CSF of neuroleptic-naive first-episode schizophrenic patients: levels of biogenic amines, substance P, and peptides derived from chromogranin A (GE-25) and secretogranin II (secretoneurin). : Biological psychiatry. 19970529.